Growth Metrics

Merck (MRK) FCF Payout Ratio (2016 - 2025)

Merck (MRK) has disclosed FCF Payout Ratio for 17 consecutive years, with 1.11 as the latest value for Q4 2025.

  • On a quarterly basis, FCF Payout Ratio rose 42.51% to 1.11 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.66, a 52.68% increase, with the full-year FY2025 number at 0.66, up 52.68% from a year prior.
  • FCF Payout Ratio was 1.11 for Q4 2025 at Merck, up from 0.3 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 10.41 in Q1 2021 to a low of 2.49 in Q4 2023.
  • A 5-year average of 1.26 and a median of 0.55 in 2022 define the central range for FCF Payout Ratio.
  • Biggest YoY gain for FCF Payout Ratio was 1108.06% in 2023; the steepest drop was 567.33% in 2023.
  • Merck's FCF Payout Ratio stood at 0.42 in 2021, then rose by 26.19% to 0.53 in 2022, then crashed by 567.33% to 2.49 in 2023, then skyrocketed by 131.15% to 0.78 in 2024, then skyrocketed by 42.51% to 1.11 in 2025.
  • Per Business Quant, the three most recent readings for MRK's FCF Payout Ratio are 1.11 (Q4 2025), 0.3 (Q3 2025), and 0.82 (Q2 2025).